Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
VTE in Cancer: Risk Factors, DOACS are Reasonable Choice, Less Recurrent VTE with Apixaban
Login to view comments.
Click here to Login
Nonmalignant Hematology